Who has invested in Empress Therapeutics?

Flagship Pioneering are named among the investors backing Empress Therapeutics.

Empress Therapeutics Funding: $50M Raised, Series A (2023)

Empress Therapeutics funding overview

Empress Therapeutics is based in Watertown, Massachusetts. Empress Therapeutics has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2023. The round record for Empress Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include Flagship Pioneering.

Empress Therapeutics at a glance

Total raised: $50M
Latest round: Series A
Latest round date: January 2023
Headquarters: Watertown, Massachusetts
Notable investors: Flagship Pioneering

Frequently asked about Empress Therapeutics funding

How much has Empress Therapeutics raised?: Empress Therapeutics has raised $50M in total disclosed funding across the rounds on record.
Who has invested in Empress Therapeutics?: Flagship Pioneering are named among the investors backing Empress Therapeutics.
What was the latest Empress Therapeutics funding round?: The most recent disclosed round is a Series A, announced in January 2023.
Where is Empress Therapeutics based?: Empress Therapeutics is based in Watertown, Massachusetts.
When did Empress Therapeutics last raise?: The last disclosed Empress Therapeutics round closed in January 2023 at Series A.

Every Empress Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Watertown at a similar stage.

Empress Therapeutics Funding: $50M Raised, Series A (2023)

Empress Therapeutics funding overview

Empress Therapeutics at a glance

Frequently asked about Empress Therapeutics funding

Companies related to Empress Therapeutics (36)

Browse related funding lists (4)